このレポートは、治療薬タイプ別（モノクローナル抗体、コルチコステロイド、ビタミン、その他の治療薬）、投与経路別（経口、非経口、局所）、流通チャネル別（病院薬局、小売薬局、オンラインチャネル）、地域別、国別の観点から、世界の甲状腺眼症治療業界の完全な分析を提供します。市場は、2018年から2022年の過去の期間、2023年の推計、および2024年から2029年の予測期間について評価されています。
この調査レポートは、地域（アメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ）および10カ国（アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド）の詳細な分析をカバーしています。さらに、調査レポートには、市場規模、年間成長と潜在力の分析、市場プレーヤーの競合調査、投資機会、需要予測などのデータが示されています。この調査では、成長指標、制約、需給リスク、その他の重要な統計も分析され、市場の進化に関連する現在および将来の市場動向の完全な評価も行われます。
予測期間である2024年から2029年にかけて、世界の甲状腺眼症治療市場は13.24%のCAGRで成長すると予測されます。世界の甲状腺眼症治療市場は、2022年の34億6,000万米ドルから2029年末までに82億4,000万米ドルを創出すると予測されます。
甲状腺眼症（TED）治療市場は、この病気の有病率の増加の結果、大幅な拡大を目の当たりにしています。バセドウ病は甲状腺に影響を及ぼす自己免疫疾患の一つであり、TED（甲状腺眼症）と関連することが多くなっています。バセドウ病のような自己免疫疾患の有病率は増加傾向にあり、それに伴って甲状腺眼症（TED）の症例数も増加しています。患者数の増加は、TED治療に対する需要の増加に寄与しています。
生物学的製剤や分子標的治療薬の登場は、TED治療の展望を変えつつあります。臨床試験では、IL-6レセプターやIGF-1レセプターなど、特定の免疫反応分子を標的とするモノクローナル抗体が可能性を示しています。これらの生物学的製剤は、免疫反応を調節し、炎症を抑え、TEDの症状を緩和するのに役立ちます。このような特殊な治療法の開発は、軽度から重度のTED患者に新たな治療選択肢を提供するものです。
目次
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
3.1 Clinical Signs Of Thyroid Eye Disease
3.2 Signs and symptoms due to excess thyroid hormones
3.3 Global Thyroid Eye Disease Treatment Market: Dashboard
3.4 Global Thyroid Eye Disease Treatment Market: Market Value Assessment, 2018-2028 (USD Million)
3.5 Impact of COVID-19 on Global Thyroid Eye Disease Treatment Market
3.6 Global Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
3.6.1 Global Thyroid Eye Disease Treatment Market, By Therapeutic Type Type Overview
3.6.2 Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
3.6.3 Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
3.6.4 Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
3.6.5 Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
3.7 Global Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
3.7.1 Global Thyroid Eye Disease Treatment Market, By Route of Administration Overview
3.7.2 Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
3.7.3 Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
3.7.4 Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
3.8 Global Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
3.8.1 Global Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
3.8.2 Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies By Value, 2018H-2028F (USD Million & CAGR)
3.8.3 Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
3.8.4 Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
4. Global Thyroid Eye Disease Treatment Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
5.1 Americas Thyroid Eye Disease Treatment Market: Snapshot
5.2 Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.3 Americas Thyroid Eye Disease Treatment Market: Key Factors
5.4 Americas Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
5.4.1 Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
5.4.2 Americas Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
5.4.3 Americas Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
5.4.4 Americas Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
5.4.5 Americas Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
5.5 Americas Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
5.5.1 Americas Thyroid Eye Disease Treatment Market, By Route of Administration Overview
5.5.2 Americas Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
5.5.3 Americas Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
5.5.4 Americas Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
5.6 Americas Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
5.6.1 Americas Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
5.6.2 Americas Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.6.3 Americas Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.6.4 Americas Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
5.7 Americas Thyroid Eye Disease Treatment Market Segmentation: By Country
5.7.1 United States Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.1.1 United States Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.7.1.2 United States Thyroid Eye Disease Treatment Market, By Route of Administration
5.7.1.3 United States Thyroid Eye Disease Treatment Market, By Distribution Channel
5.7.2 Canada Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.2.1 Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.7.2.2 Canada Thyroid Eye Disease Treatment Market, By Route of Administration
5.7.2.3 Canada Thyroid Eye Disease Treatment Market, By Distribution Channel
5.7.3 Rest of Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.3.1 Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.7.3.2 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration
5.7.3.3 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration
6. Europe Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
6.1 Europe Thyroid Eye Disease Treatment Market: Snapshot
6.2 Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.3 Europe Thyroid Eye Disease Treatment Market: Key Factors
6.4 Europe Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
6.4.1 Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
6.4.2 Europe Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
6.4.3 Europe Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
6.4.4 Europe Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
6.4.5 Europe Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
6.5 Europe Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
6.5.1 Europe Thyroid Eye Disease Treatment Market, By Route of Administration Overview
6.5.2 Europe Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
6.5.3 Europe Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
6.5.4 Europe Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
6.6 Europe Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
6.6.1 Europe Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
6.6.2 Europe Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.6.3 Europe Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.6.4 Europe Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
6.7 Europe Thyroid Eye Disease Treatment Market Segmentation: By Country
6.7.1 Germany Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.1.1 Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.1.2 Germany Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.1.3 Germany Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.2 United Kingdom Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.2.1 United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.2.2 United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.2.3 United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.3 France Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.3.1 France Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.3.2 France Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.3.3 France Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.4 Italy Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.4.1 Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.4.2 Italy Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.4.3 Italy Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.5 Spain Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.5.1 Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.5.2 Spain Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.5.3 Spain Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.6 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.6.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.6.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.6.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.6 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.6.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.6.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.6.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel
7. Asia-Pacific Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
7.1 Asia-Pacific Thyroid Eye Disease Treatment Market: Snapshot
7.2 Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.3 Asia-Pacific Thyroid Eye Disease Treatment Market: Key Factors
7.4 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
7.4.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
7.4.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
7.4.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
7.4.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
7.4.5 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
7.5 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
7.5.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration Overview
7.5.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
7.5.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
7.5.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
7.6 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
7.6.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
7.6.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.6.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.6.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
7.7 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Country
7.7.1 China Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.1.1 China Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.1.2 China Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.1.3 China Thyroid Eye Disease Treatment Market, By Distribution Channel
7.7.2 Japan Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.1.1 Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.1.2 Japan Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.1.3 Japan Thyroid Eye Disease Treatment Market, By Distribution Channel
7.7.3 India Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.3.1 India Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.3.2 India Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.3.3 India Thyroid Eye Disease Treatment Market, By Distribution Channel
7.7.5 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.5.1 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.5.2 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.5.3 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel
8. Middle-East & Africa Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
8.1 Middle-East & Africa Thyroid Eye Disease Treatment Market: Snapshot
8.2 Middle-East & Africa Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
8.3 Middle-East & Africa Thyroid Eye Disease Treatment Market: Key Factors
8.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
8.4.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
8.4.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
8.4.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
8.4.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
8.4.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
8.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
8.5.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Route of Administration Overview
8.5.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
8.5.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
8.5.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
8.6 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
8.6.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Distribution Channel: Overview
8.6.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.6.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.6.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Global Thyroid Eye Disease Treatment Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter’s Five Forces Analysis
10.1 Porter’s Five Forces Model
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Thyroid Eye Disease Treatment Market
11.4 Company Profiles
11.4.1 Horizon Therapeutics
11.4.2 GSK plc
11.4.3 Santen Pharmaceuticals
11.4.4 Viridian Therapeutics
11.4.5 Bioxcel Therapeutics
11.4.6 Novartis AG
11.4.7 Roche Holding AG
11.4.8 Sanofi
11.4.9 Teva Pharmaceuticals
11.4.10 Abbvie Inc
List of Figures
Figure 1: Global Thyroid Eye Disease Treatment Market Size, By Value, 2019-2022 (USD Million)
Figure 2: Global Thyroid Eye Disease Treatment Market Size, By Value, 2023-2029 (USD Million)
Figure 3: Global Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 4: Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 5: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Monoclonal Antibodies, 2019-2029 (USD Million)
Figure 6: Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 7: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Corticosteroids, 2019-2029 (USD Million)
Figure 8: Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 9: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Vitamins, 2019-2029 (USD Million)
Figure 10: Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 11: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Other Therapeutics, 2019-2029 (USD Million)
Figure 12: Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 13: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Oral, 2019-2029 (USD Million)
Figure 14: Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 15: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Parenteral, 2019-2029 (USD Million)
Figure 16: Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2019H-2029F (USD Million & CAGR)`
Figure 17: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Topical, 2019-2029 (USD Million)
Figure 18: Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 19: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Hospital Pharmacies, 2019-2029 (USD Million)
Figure 20: Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 21: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Retail Pharmacies, 2019-2029 (USD Million)
Figure 22: Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 23: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Online Channel, 2019-2029 (USD Million)
Figure 24: Americas Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 25: Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 26: Americas Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 27: Americas Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 28: Americas Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 29: Americas Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 30: Americas Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 31: Americas Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 32: Americas Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 33: Americas Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 34: Americas Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 35: Americas Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 36: United States Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 37: United States Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 38: United States Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 39: United States Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value, 2022 (%)
Figure 40: United States Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 41: Canada Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 42: Canada Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 43: Canada Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 44: Canada Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 45: Canada Thyroid Eye Disease Treatment Market Share, Distribution Channel, 2022 (%)
Figure 46: Rest of Americas Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 47: Rest of Americas Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 48: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 49: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 50: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 51: Europe Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 52: Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 53: Europe Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 54: Europe Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 55: Europe Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 56: Europe Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 57: Europe Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 58: Europe Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 59: Europe Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 60: Europe Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 61: Europe Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 62: Europe Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 63: Germany Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 64: Germany Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 65: Germany Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 66: Germany Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 67: Germany Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 68: United Kingdom Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 69: United Kingdom Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 70: United Kingdom Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 71: United Kingdom Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 72: United Kingdom Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 73: France Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 74: France Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 75: France Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 76: France Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 77: France Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 78: Italy Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 79: Italy Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 80: Italy Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 81: Italy Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 82: Italy Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 83: Spain Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 84: Spain Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 85: Spain Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 86: Spain Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 87: Spain Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 88: Rest of Europe Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 89: Rest of Europe Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 90: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 91: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 92: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 93: Asia Pacific Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 94: Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 95: Asia Pacific Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 96: Asia Pacific Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 97: Asia Pacific Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 98: Asia Pacific Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 99: Asia Pacific Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 100: Asia Pacific Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 101: Asia Pacific Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 102: Asia Pacific Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 103: Asia Pacific Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 104: Asia Pacific Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 105: China Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 106: China Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 107: China Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 108: China Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 109: China Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 110: Japan Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 111: Japan Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 112: Japan Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 113: Japan Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 114: Japan Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 115: India Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 116: India Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 117: India Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 118: India Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 119: India Thyroid Eye Disease Treatment Market Share, Distribution Channel, 2022 (%)
Figure 120: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 121: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 122: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 123: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 124: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 125: Middle East and Africa Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 126: Middle East and Africa Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 127: Middle East and Africa Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 128: Middle East and Africa Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 129: Middle East and Africa Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 130: Middle East and Africa Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 131: Middle East and Africa Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 132: Middle East and Africa Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 133: Middle East and Africa Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 134: Middle East and Africa Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 135: Middle East and Africa Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 136: Middle East and Africa Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 137: Market Share of Prominent Companies of Thyroid Eye Disease Treatment Market, 2022 (%)
Figure 138: GSK PLC Revenue, 2020-2022 (USD Million)
Figure 139: GSK PLC Revenue, By Business Segments, 2022 (%)
Figure 140: GSK PLC Revenue, By Geography Segment, 2022 (%)
Figure 141: Santen Revenue, 2020-2022 (USD Million)
Figure 142: Santen Revenue, By Geography Segment, 2022 (%)
Figure 143: Santen Revenue, By Geography Segment, 2022 (%)
Figure 144: Novartis Revenue, 2020-2022 (USD Million)
Figure 145: Novartis Revenue, By Business Segments, 2022 (%)
Figure 146: Novartis Revenue, By Geographical Segments, 2022 (%)
Figure 147: Roche Revenue, 2020-2022 (USD Million)
Figure 148: Roche Revenue, By Business Segments, 2022 (%)
Figure 149: Roche Revenue, By Business Segments, 2022 (%)
Figure 150: Sanofi Revenues, 2020-2022 (USD Million)
Figure 151: Sanofi Revenues, By Geographic Segments, 2022 (%)
Figure 152: Sanofi Revenue, By Business Segments, 2022 (%)
Figure 153: Teva Pharmaceuticals Revenues, 2020-2022 (USD Million)
Figure 154: Teva Pharmaceuticals Revenue, By Geographical Segments, 2022 (%)
Figure 155: AbbVie Inc. Revenues, 2020-2022 (USD Million)
Figure 156: AbbVie Inc. Revenue, Product Sales by Business Segment, 2022 (%)
Figure 157: AbbVie Inc. Revenue, By Geographical Segments, 2022 (%)
List of Tables
Table A1: Changes in Eyelid
Table A2: Changes in Facial Muscles
Table A3: Changes in Extraocular Movement
Table A4: Changes in Pupil
Table A5: Other Signs
Table A6: Clinical manifestation of thyrotoxicosis
Table A7: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A8: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A9: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A10: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A11: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A12: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A13: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A14: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A15: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A16: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A17: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A18: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A19: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A20: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A21: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A22: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A23: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A24: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A25: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A26: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A27: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A28: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A29: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A30: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A31: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A32: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A33: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A34: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A35: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A36: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A37: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A38: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A39: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A40: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A41: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A42: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A43: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A44: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A45: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A46: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A47: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A48: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A49: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A50: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A51: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A52: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A53: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A54: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A55: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A56: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A57: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A58: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A59: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A60: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A61: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A62: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A63: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A64: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A65: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A66: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A67: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A68: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A69: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A70: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A71: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A72: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A73: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A74: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A75: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A76: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A77: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A78: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A79: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A80: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A81: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A82: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A83: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A84: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A85: GSK PLC Key Company Financials, 2020-2022
Table A86: Santen Key Company Financials, 2020-2022
Table A87: Novartis Key Company Financials, 2020-2022
Table A88: Roche Key Company Financials, 2020-2022
Table A89: Sanofi Key Financials, 2020-2022
Table A90: Teva Pharmaceuticals Key Financials, 2020-2022
Table A91: AbbVie Inc. Key Company Financials, 2020-2022
Table A86: Santen Key Company Financials, 2020-2022
Table A87: Novartis Key Company Financials, 2020-2022
Table A88: Roche Key Company Financials, 2020-2022
Table A89: Sanofi Key Financials, 2020-2022
Table A90: Teva Pharmaceuticals Key Financials, 2020-2022
Table A91: AbbVie Inc. Key Company Financials, 2020-2022
